Treatment patterns and healthcare resource utilization in patients with FLT3 ‐mutated and wild‐type acute myeloid leukemia: A medical chart study-Reference-Cited by-同舟云学术

Treatment patterns and healthcare resource utilization in patients with FLT3 ‐mutated and wild‐type acute myeloid leukemia: A medical chart study

Published:2019-02-05 Issue:4 Volume:102 Page:341-350
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Griffin James D.¹,Yang Hongbo²,Song Yan²,Kinrich David²,Shah Manasee V.³,Bui Cat N.³

Affiliation:

1. Dana‐Farber Cancer Institute Boston Massachusetts

2. Analysis Group, Inc. Boston Massachusetts

3. Astellas Pharma US, Inc. Northbrook Illinois

Funder

Astellas Pharma US

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13205

Reference36 articles.

1. Acute Myeloid Leukemia: A Concise Review

2. Systematic literature review of the global incidence and prevalence of myelodysplastic syndrome and acute myeloid leukemia;Lubeck DP;Blood,2016

3. National Cancer Institute.Cancer Stat Facts: Leukemia ‐ Acute Myeloid Leukemia (AML).2017. Available at:https://seer.cancer.gov/statfacts/html/amyl.html. Accessed March 2018.

4. Cytogenetic profile of de novo acute myeloid leukemia patients in Malaysia;Meng CY;Int J Biomed Sci,2013

5. ASCO.Acute Myeloid Leukemia (AML): Statistics.2017. Available at:https://www.cancer.net/cancer-types/leukemia-acute-myeloid-aml/statistics. Accessed March 2018.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Patterns and FLT3 Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study;Therapeutics and Clinical Risk Management;2024-02

2. Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study;European Journal of Haematology;2022-04-13

3. Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy;International Journal of Hematology;2022-04-08

4. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy^*;Leukemia & Lymphoma;2022-02-11

5. Post‐transplant maintenance therapy in patients with FLT3 ‐mutated acute myeloid leukemia: Real‐world treatment patterns and outcomes;European Journal of Haematology;2021-08-11